Lyell Immunopharma Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.10 | 0.26 | 0.09 | 0.19 | 0.20 | 0.22 | 0.23 | 0.23 | 0.05 | 2.90 | 0.00 | 3.88 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.24 | – | – | 0.33 | 0.33 | 0.30 | 0.34 | 0.37 | 0.40 | 0.36 | 0.41 | 0.40 | 0.40 | 0.38 | – | 0.38 | – | 0.21 | – | 0.14 | 0.11 | – | – | |
| 0.10 | 0.26 | 0.09 | 0.19 | -0.04 | 0.22 | 0.23 | -0.10 | -0.28 | 2.60 | -0.34 | 3.51 | -0.40 | -0.36 | -0.40 | -0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.11 | 0.00 | -0.10 | |
| 2.07 | 8.15 | 2.04 | 2.85 | 2.32 | 3.89 | 2.62 | 1.26 | 2.69 | 3.13 | 2.93 | 2.68 | 3.22 | 3.38 | 3.18 | 3.29 | 3.40 | 3.15 | 3.08 | 3.65 | 2.94 | 2.36 | 1.54 | 3.05 | 1.67 | 1.69 | 6.70 | |
| 0.72 | 0.80 | 1.13 | 1.21 | 1.37 | 1.60 | 1.77 | 2.63 | 2.82 | 2.47 | 2.10 | 0.00 | 1.54 | 1.52 | 1.23 | 1.04 | 1.06 | 0.96 | 0.92 | 1.09 | 0.95 | 0.66 | 0.59 | 0.62 | 0.44 | 0.41 | 1.73 | |
| 2.78 | 8.86 | 3.16 | 3.39 | 3.68 | 5.48 | 4.33 | 3.89 | 5.51 | 5.61 | 5.04 | 4.79 | 4.77 | 4.90 | 4.42 | 4.33 | 4.37 | 4.04 | 3.94 | 15.09 | 3.89 | 3.19 | 2.04 | 3.59 | 2.00 | 2.03 | 8.12 | |
| -2.68 | -8.60 | -3.07 | -3.21 | -3.73 | -5.26 | -4.10 | -3.98 | -5.79 | -3.01 | -5.37 | -1.28 | -5.16 | -5.27 | -4.82 | -4.73 | -4.37 | -4.04 | -3.94 | -15.09 | -3.89 | -3.19 | -2.04 | -3.59 | -2.11 | -2.03 | -8.22 | |
| 0.19 | 0.16 | 0.09 | 0.05 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.08 | 0.18 | 0.29 | 5.26 | 0.42 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.37 | -8.44 | -2.98 | -3.15 | -4.46 | -5.25 | -4.08 | -6.90 | -5.58 | -2.95 | -5.66 | -0.67 | -5.37 | -5.11 | -4.05 | -4.18 | -4.77 | -3.59 | -3.48 | -14.40 | -3.54 | -2.89 | -2.13 | -8.23 | -1.10 | -1.92 | -10.64 | |
| -0.19 | -0.16 | -0.09 | -0.10 | -0.03 | -0.02 | -0.02 | -0.03 | -0.04 | -0.08 | 0.31 | -0.20 | 5.26 | -0.19 | -0.53 | 0.40 | 0.39 | – | – | – | – | – | – | – | – | – | – | |
| -2.37 | -8.44 | -2.98 | -3.15 | -4.46 | -5.25 | -4.08 | -6.90 | -5.58 | -2.95 | -5.66 | -0.67 | -5.37 | -5.11 | -4.05 | -4.18 | -4.77 | -3.59 | -3.48 | -14.40 | -3.54 | -2.89 | -2.13 | -8.23 | -1.10 | -1.92 | -10.64 | |
| -2.61 | -8.52 | -2.98 | -3.72 | -4.22 | -5.00 | -3.74 | -6.57 | -5.26 | -2.65 | -5.32 | -0.30 | -4.96 | -4.74 | -3.64 | -3.78 | -4.38 | -3.20 | -3.11 | -4.33 | -3.30 | -2.88 | -1.99 | -8.09 | -1.00 | -1.82 | -10.23 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.